Vita 34 AG
XETRA:V3V
Vita 34 AG
XETRA:V3V
Price:
4.76 EUR
Updated:
May 20, 2024
Vita 34 AG
Total Liabilities
|
Vita 34 AG
Total Liabilities Peer Comparison
Comparables:
F
FME
FRE
E
1846
SYAB
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vita 34 AG
XETRA:V3V
|
Total Liabilities
€134.8m
|
CAGR 3-Years
67%
|
CAGR 5-Years
35%
|
CAGR 10-Years
25%
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Total Liabilities
€20.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Total Liabilities
€24.8B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
0%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Total Liabilities
HK$618.8m
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Synlab AG
XETRA:SYAB
|
Total Liabilities
€2.3B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Total Liabilities?
Total Liabilities
134.8m
EUR
134.8m
EUR
Based on the financial report for Dec 31, 2023, Vita 34 AG's Total Liabilities amounts to 134.8m EUR.
What is Vita 34 AG's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
25%
25%
Over the last year, the Total Liabilities growth was 0%. The average annual Total Liabilities growth rates for Vita 34 AG have been 67% over the past three years , 35% over the past five years , and 25% over the past ten years .
You don't have any saved screeners yet
